Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Zhen Yang is a senior scientist of biopharmaceutics at Merck. Prior to joining Merck, he led a clinical bioanalytical lab as Supervisor at Texas Medical Toxicology for 1 year. He obtained his Ph.D. at University of Houston focusing on oral drug absorption, metabolism, and related drug transporters. In his master program at Shanghai Institute of Pharmaceutical Industry, he worked on development of transdermal drug formulation. He published more than 25 papers in several peer-reviewed journals, 2 book chapters and 10 more conference abstracts in the areas of biopharmaceutics, formulation and bioanalysis.
His main research area is to support oral formulation development at various development stages. In addition, Zhen will lead and collaborate with colleagues in identifying and evaluating opportunities for alternate route of drug delivery in both drug discovery and late stage development.
Research Article: J Phys Chem Biophys 2015, 5: 192
Research Article: Mol Biol 2012, 1:1